Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             48 results found
no title author magazine year volume issue page(s) type
1 A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses Talaat, Adel M.
 2001
 20 3-4 p. 538-544
7 p.
 article
2 Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes Nanan, Ralph
 2001
 20 3-4 p. 498-504
7 p.
 article
3 Ad Hoc Working Group on acellular pertussis vaccines, World Health Organisation, Geneva, 27–28 July 2000 Corbel, M.J.
 2001
 20 3-4 p. 288-291
4 p.
 article
4 Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination Marth, E
 2001
 20 3-4 p. 532-537
6 p.
 article
5 ANNOUNCEMENT 2001
 20 3-4 p. 636-
1 p.
 article
6 An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice Niethammer, Andreas G
 2001
 20 3-4 p. 421-429
9 p.
 article
7 A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin–neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains Babai, Ilan
 2001
 20 3-4 p. 505-515
11 p.
 article
8 Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice Ramı́rez, José Robinson
 2001
 20 3-4 p. 455-461
7 p.
 article
9 A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC) Stratford, Richard
 2001
 20 3-4 p. 516-525
10 p.
 article
10 BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria–tetanus antigens Garly, May-Lill
 2001
 20 3-4 p. 468-474
7 p.
 article
11 Birth of MHC-defined rhesus monkeys produced by assisted reproductive technology Schramm, R.Dee
 2001
 20 3-4 p. 603-607
5 p.
 article
12 Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers Ölander, Rose-Marie
 2001
 20 3-4 p. 336-341
6 p.
 article
13 Circumvention of MHC class II restriction by genetic immunization Schuler, Kilian
 2001
 20 3-4 p. 630-634
5 p.
 article
14 Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP119 expressed in distinct bacterial vectors Cunha, Maristela G
 2001
 20 3-4 p. 385-396
12 p.
 article
15 Covalent complexes of antigen and α2-macroglobulin: evidence for dramatically-increased immunogenicity Cianciolo, George J
 2001
 20 3-4 p. 554-562
9 p.
 article
16 Developing Country Vaccine Manufacturers Network (DCVMN), 26–27 April 2001, Bandung, Indonesia Henriks, J.
 2001
 20 3-4 p. 285-287
3 p.
 article
17 DNA-mediated vaccination against infectious bursal disease in chickens Chang, Hua Chen
 2001
 20 3-4 p. 328-335
8 p.
 article
18 DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice Chlichlia, Katerina
 2001
 20 3-4 p. 439-447
9 p.
 article
19 Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals Bolmstedt, Anders
 2001
 20 3-4 p. 397-405
9 p.
 article
20 Epidemiology of primary varicella hospitalizations in Spain Gil, Angel
 2001
 20 3-4 p. 295-298
4 p.
 article
21 Erratum to “Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin” [Vaccine 19 (2001) 3241–3247] Fellows, P.F.
 2001
 20 3-4 p. 635-
1 p.
 article
22 Identification of an association between HLA class II alleles and low antibody levels after measles immunization Poland, Gregory A.
 2001
 20 3-4 p. 430-438
9 p.
 article
23 Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice Da’dara, Akram A
 2001
 20 3-4 p. 359-369
11 p.
 article
24 Inactivation of viruses by aziridines Brown, F.
 2001
 20 3-4 p. 322-327
6 p.
 article
25 Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope Shams, Homayoun
 2001
 20 3-4 p. 577-585
9 p.
 article
26 Interleukin-2 fusion protein with anti-CD3 single-chain Fv (sFv) selectively protects T cells from dexamethasone-induced apoptosis Kim, Eui J
 2001
 20 3-4 p. 608-615
8 p.
 article
27 Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China Shi, Fuhui
 2001
 20 3-4 p. 462-467
6 p.
 article
28 Laboratory testing of whole cell pertussis vaccine: a WHO proficiency study using the Kendrick test Xing, D
 2001
 20 3-4 p. 342-351
10 p.
 article
29 Lack of contact transmission of recombinant Marek’s disease virus type 1 expressing the fusion protein of Newcastle disease virus Okamura, H
 2001
 20 3-4 p. 483-489
7 p.
 article
30 Large scale safety study of a liquid hexavalent vaccine (D-T-acP–IPV–PRP∼T–HBs) administered at 2, 4, 6 and 12–14 months of age Liese, J.G.
 2001
 20 3-4 p. 448-454
7 p.
 article
31 Local immune responses to influenza antigen are synergistically enhanced by the adjuvant ISCOMATRIX® Windon, R.G.
 2001
 20 3-4 p. 490-497
8 p.
 article
32 Marburg virus vaccines: comparing classical and new approaches Hevey, M.
 2001
 20 3-4 p. 586-593
8 p.
 article
33 Measles vaccine immunogenicity and antibody persistence in 12- vs. 15-month-old infants Arya, Subhash C.
 2001
 20 3-4 p. 294-
1 p.
 article
34 Modeling the economic benefits of an AIDS vaccine Bishai, David
 2001
 20 3-4 p. 526-531
6 p.
 article
35 Mucosal and systemic HIV-1 Env-specific CD8+ T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector Shata, Mohamed T.
 2001
 20 3-4 p. 623-629
7 p.
 article
36 Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity Singh, Manmohan
 2001
 20 3-4 p. 594-602
9 p.
 article
37 Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice Hart, Mary Kate
 2001
 20 3-4 p. 616-622
7 p.
 article
38 Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen Paoletti, Lawrence C
 2001
 20 3-4 p. 370-376
7 p.
 article
39 Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines Andre, F.E.
 2001
 20 3-4 p. 292-293
2 p.
 article
40 Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults Feikin, Daniel R.
 2001
 20 3-4 p. 545-553
9 p.
 article
41 Rational development of prophylactic HIV vaccines based on structural and regulatory proteins Mooij, Petra
 2001
 20 3-4 p. 304-321
18 p.
 article
42 Rectal immunization with antigen-containing microspheres induces stronger Th2 responses than oral immunization: a new method for vaccination Nakase, Hiroshi
 2001
 20 3-4 p. 377-384
8 p.
 article
43 Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine de Kleijn, Ester
 2001
 20 3-4 p. 352-358
7 p.
 article
44 T cell responses to major membrane protein II (MMP II) of Mycobacterium leprae are restricted by HLA-DR molecules in patients with leprosy Ohyama, Hideki
 2001
 20 3-4 p. 475-482
8 p.
 article
45 Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland Gzyl, Anna
 2001
 20 3-4 p. 299-303
5 p.
 article
46 The role of the individual amino acids of a GnRH-tandem-dimer peptide used as an antigen for immunocastration of male piglets determined with systematic alanine replacements Turkstra, J.A.
 2001
 20 3-4 p. 406-412
7 p.
 article
47 Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy Koesling, Jan
 2001
 20 3-4 p. 413-420
8 p.
 article
48 Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates Lee, Sandra A
 2001
 20 3-4 p. 563-576
14 p.
 article
                             48 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands